Prusty talks about his upcoming research on a podcast

Osaca

Senior Member
Messages
344

So, to sum up his latest Twitter posts (I hope I disentangled this correctly. He might be a great scientist, but his communcation is terrible.):
He has 2 markers. The first one on thursday will be for a majority of ME in general and LC with neurological symptoms, and correlates with disease severity.
The second one in June will be for LC and severe ME, and that's the missing protein.
Also, the first one might just be a marker, the second one a clear biomarker.
I think you untangled what he's said here correctly, however he previously also said that the missing protein biomarker correlates with disease severity which doesn't really fit the above picture IMO.
 
Messages
181
I think you untangled what he's said here correctly, however he previously also said that the missing protein biomarker correlates with disease severity which doesn't really fit the above picture IMO.
Yes, i was wondering about this, too. My desription is based on him saying that he won't talk about the missing protein this week. We'll see, I guess.
Edit: I edited my above post to add that.
 

Osaca

Senior Member
Messages
344
So in that example they are suppressing some part of overactive immune system ( speculated to be involved in covid mortality ) by use of an artificial antibody ? is that actually relevant to our situation with CFS ? i'm not seeing the connection with prustys thing.
The only connection I see to Prusty is that he recently said that the problem (or one of the problems) lies in the complement system. That is exactly what this monoclonal ab adresses, however there are several other pathways and mechanisms in the complement system.
 
Last edited:
Messages
56
The missing protein will not be a part of my talk this week. It’s just way too much to cover in 15 minutes. The missing proteins takes us deep into long COVID story and opens up a pandora box. That’s something requires more time to talk and will be a part of the full paper.
What is this pandora box reference? I hope he's not headed into a Judy Mikovits type situation...
 

Rvanson

Senior Member
Messages
312
Location
USA
Dont, think that he knows anything about ME/CFS if he thinks an anti-psychotic like Abilify is going to help anyone. It's a psych med.
 
Messages
31
At the conference in Berlin he was talking about fibronectin.
I did not understand much about his talk but it seems that both plasma fibronectin as well as celullar fibronectin is increased in ME/CFS.

I attached the relevant slides. Sry for the bad quality.

Here's what chatGPT gives me on fibronectin:
Fibronectin is a glycoprotein that plays a critical role in cellular adhesion and the organization of the extracellular matrix. It is found in many tissues and body fluids, including blood, and is involved in a variety of biological processes such as wound healing, embryonic development, and tissue repair. Fibronectin is produced by cells such as fibroblasts, endothelial cells, and platelets, and is composed of repeating structural domains called type I, II, and III modules. It interacts with other extracellular matrix proteins and cell surface receptors to mediate cell adhesion, migration, and signaling. Dysfunction in fibronectin can lead to various diseases and disorders, including cancer, cardiovascular disease, and fibrosis.
 

Attachments

  • IMG_7058.jpg
    IMG_7058.jpg
    440.8 KB · Views: 40
  • IMG_7057.jpg
    IMG_7057.jpg
    346.3 KB · Views: 27
Last edited:

BrightCandle

Senior Member
Messages
1,213
I am not sure quite what to make of that talk. Fibronectin is elevated and correlates with the disease. We also have a few key IgM antibodies that are low that determine Severe v Mild/Moderate and health controls. HHV6 seems to be in there disrupting the cellular cytoskeleton which is maybe linked with the Fibronectin being elevated. The fibronectin seems to fire up all the IgG response and immune response.
 

Osaca

Senior Member
Messages
344
I am not sure quite what to make of that talk. Fibronectin is elevated and correlates with the disease. We also have a few key IgM antibodies that are low that determine Severe v Mild/Moderate and health controls. HHV6 seems to be in there disrupting the cellular cytoskeleton which is maybe linked with the Fibronectin being elevated. The fibronectin seems to fire up all the IgG response and immune response.
How big were the samples sizes seems like a key question once again.
 

hapl808

Senior Member
Messages
2,332
Ten people with ME/CFS in total or 10 severe, 10 mild, etc., do you recall ? 10 in total is an almost negiliable number.
I always wonder this about studies when it's not clear. Someone with mild or moderate improving is pretty meaningless outside of a DB-RCT because it seems many people mild or moderate will improve if nothing is done and they just take it easy. Severe, in my opinion, seems like a different beast. There seem to be much fewer credible reports of someone with severe ME/CFS for years then improving significantly with treatment. Most of what I see discussed is, "I went from being bedbound 22 hours a day to being bedbound for 20 hours a day." Admittedly a big quality of life improvement, but still totally disabled.
 
Back